Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.04M Sell
13,444
-942
-7% -$143K ﹤0.01% 2952
2025
Q4
$1.53M Sell
14,386
-626
-4% -$70.3K ﹤0.01% 3136
2025
Q3
$1.58M Sell
15,012
-6,211
-29% -$556K ﹤0.01% 3134
2025
Q2
$1.79M Buy
+21,223
New +$1.43M ﹤0.01% 2998
2025
Q1
Sell
-25,129
Closed -$2.03M 4034
2024
Q4
$2.03M Buy
25,129
+3,635
+17% +$286K ﹤0.01% 2914
2024
Q3
$1.72M Buy
21,494
+19,358
+906% +$1.89M ﹤0.01% 2991
2024
Q2
$268K Sell
2,136
-5,525
-72% -$527K ﹤0.01% 3621
2024
Q1
$642K Buy
+7,661
New +$602K ﹤0.01% 3337
2022
Q1
Sell
-27,176
Closed -$1.25M 3949
2021
Q4
$1.25M Buy
27,176
+2,648
+11% +$113K ﹤0.01% 3153
2021
Q3
$994K Buy
+24,528
New +$945K ﹤0.01% 3165

Other funds holding CAMT

Ameriprise's CAMT Position: Q1 2026 in Review

Ameriprise reduced its Camtek (CAMT) stake by 6.5% in Q1 2026, selling an estimated $143K and leaving 13,444 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

Ameriprise first reported a position in CAMT in Q3 2021 and has held it in 10 quarters since. 222 funds tracked by Wall St. Rank hold CAMT as of Q1 2026.

  • Ameriprise held 13,444 shares of Camtek worth $2.04M as of Q1 2026.
  • Ameriprise sold 942 Camtek shares in Q1 2026, an estimated $143K.
  • Camtek made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2952 holding.
  • Ameriprise first reported a position in Camtek in Q3 2021 and has held it in 10 quarters since.
  • 222 funds tracked by Wall St. Rank held Camtek as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.